OPKO Health, Inc. (OPK)

OPKO Health Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, OPKO Health stock has a consensus rating of "Buy" and an average price target of $3.76. The average 1-year stock price forecast is 196.06% higher than the current stock price, while the lowest is $1.30 (+2.36%) and the highest is $8.50 (+569.29%).

Price Target: $3.76 (+196.06%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.30	$3.76	$3.00	$8.50
Change	+2.36%	+196.06%	+136.22%	+569.29%

* Price targets were last updated on Oct 31, 2025.

Analyst Ratings

The average analyst rating for OPKO Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	0	0
Buy	1	1	1	1	0	0
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	5	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington Research	Barrington Research	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Apr 29, 2026
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $2.25 → $1.5	Buy	Maintains	$2.25 → $1.5	+18.11%	Mar 2, 2026
Brian Cheng JP Morgan	JP Morgan	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Nov 20, 2025
Maury Raycroft Jefferies	Jefferies	Strong Buy → Hold Downgrades $2 → $1.6	Strong Buy → Hold	Downgrades	$2 → $1.6	+25.98%	Oct 31, 2025
Michael Petusky Barrington Research	Barrington Research	Buy Maintains $2.25	Buy	Maintains	$2.25	+77.17%	Oct 30, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

541.71M

Decreased by -10.74%

from 606.88M

Revenue Next Year

573.38M

Increased by 5.85%

from 541.71M

EPS This Year

-0.31

from -0.30

EPS Next Year

-0.27

from -0.31

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.77B	1.00B	863.50M	713.14M	606.88M	541.71M	573.38M
Revenue Growth	23.64%	-43.42%	-14.01%	-17.41%	-14.90%	-10.74%	5.85%
EPS	-0.05	-0.46	-0.25	-0.08	-0.30	-0.31	-0.27
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030	2031	2032	2033
High	571.2M	617.9M
Avg	541.7M	573.4M
Low	516.7M	515.8M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030	2031	2032	2033
High	-5.9%	14.1%
Avg	-10.7%	5.8%
Low	-14.9%	-4.8%

EPS Forecast

EPS	2026	2027	2028
High	-0.26	-0.11
Avg	-0.31	-0.27
Low	-0.37	-0.36

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.